The Role of Blood Pressure and Aldosterone in the Production of Hemorrhagic Stroke in Captopril-Treated Hypertensive Rats
- 1 September 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 28 (9) , 1821-1829
- https://doi.org/10.1161/01.str.28.9.1821
Abstract
Background and Purpose We tested the hypothesis that the lowering of plasma aldosterone levels contributed to the antistroke effects of captopril treatment in Wistar Kyoto stroke-prone spontaneously hypertensive rats (SHRSP). Methods The suppression of plasma aldosterone by captopril treatment (50 mg · kg –1 · d –1 ) was prevented by the subcutaneous infusion of aldosterone into captopril-treated SHRSP. We studied the effect this had on blood pressure (BP) and stroke development. Results SHRSP fed a Japanese-style diet containing 4% NaCl developed hypertension and a 100% mortality associated with intracerebral hemorrhage by 14 weeks of age. Captopril treatment from 6 weeks of age did not lower the BP but increased survival past 35 weeks of age. Hydralazine treatment (40 to 80 mg/L of drinking water) lowered BP in SHRSP but was less effective than captopril in retarding stroke. Plasma aldosterone levels were elevated with age in SHRSP after 10 weeks and were higher in poststroke versus prestroke SHRSP. Captopril treatment suppressed plasma aldosterone. When we elevated plasma aldosterone in captopril-treated SHRSP to levels between those present in untreated pre- and poststroke SHRSP, the ability of captopril to retard stroke development was negated. The effects of aldosterone were mimicked by deoxycorticosterone (40 mg/kg, SC2 times/wk) but not by dexamethasone (0.1 mg · kg –1 · d –1 , SC). Spironolactone treatment (20 mg · kg –1 · d –1 , SC) of SHRSP reduced BP but had little effect on stroke development. Conclusions Elevations in plasma aldosterone enhance stroke development within captopril-treated SHRSP through mechanisms that do not involve stimulation of mineralocorticoid receptors or the enhancement of hypertension. The antistroke effects of captopril treatment may be partially mediated through the suppression of plasma aldosterone.Keywords
This publication has 17 references indexed in Scilit:
- Rapid Aldosterone Signaling in Vascular Smooth-Muscle Cells - Involvement of Phospholipase-C, Diacylglycerol and Protein-Kinase-C-αBiochemical and Biophysical Research Communications, 1995
- Aldosterone specific membrane receptors, rapid activation of the sodium-hydrogen exchanger, and cardiovascular implicationsCardiovascular Research, 1995
- Rapid Effects of Aldosterone on Free Intracellular Calcium in Vascular Smooth Muscle and Endothelial Cells: Subcellular Localization of Calcium Elevations by Single Cell ImagingBiochemical and Biophysical Research Communications, 1994
- Histopathological Investigation on Salt-Loaded Stroke-Prone Spontaneously Hypertensive Rats, Whose Biochemical Parameters of Renal Dysfunction Were Ameliorated by Administration of ImidaprilThe Japanese Journal of Pharmacology, 1994
- Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockadeJournal Of Hypertension, 1993
- Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.Hypertension, 1992
- Cerebral vascular changes associated with hemorrhagic stroke in hypertensionCanadian Journal of Physiology and Pharmacology, 1992
- Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertensionBiochemical and Biophysical Research Communications, 1991
- Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats.Hypertension, 1990
- Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats.Hypertension, 1989